全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

A Sensitive Spectrophotometric Estimation of Nimodipine in Tablets and Injection Using Phloroglucinol

DOI: 10.1155/2013/980754

Full-Text   Cite this paper   Add to My Lib

Abstract:

A rapid, simple, and sensitive spectrophotometric method has been described for the determination of nimodipine in bulk drug, tablets, and injection. The proposed method is based on the diazotization of reduced nimodipine with nitrous acid followed by coupling with phloroglucinol to form colored azo dye and showing absorption maximum ( ) at 410?nm. The formed colored azo dye is stable for about more than 2?h. The method obeyed Beer’s law over the concentration range of 0–25?μg/mL and the corresponding molar absorptivity value is ?L/moL/cm. The Sandell sensitivity values limits of detection (LOD) and quantification (LOQ) values have also been reported for the developed method. The accuracy and precision of the method was evaluated on intra- and interday basis; the relative error (%RE) and the relative standard deviation (RSD) were <2.0%. All variables have been optimized and the presented reaction sequence was applied to the analysis of nimodipine in bulk drug, tablets, and injections. The performance of this method was evaluated in terms of Student’s -test and variance ratio -test to find out the significance of proposed method over the reference method. 1. Introduction Nimodipine (NMD), chemically known as isopropyl-2-methoxyethyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine dicarboxylate (Figure 1), is a dihydropyridine calcium channel blocker that acts by relaxing the arterial smooth muscle. It is known for its preferential action on cerebral blood vessels and its potential cytoprotective effects by reducing calcium influx into nerve cells [1]. Nimodipine has also been used in the other cerebrovascular disorders, such as ischemic stroke, hypertension, and multi-infarct dementia [2]. It increases blood flow to injured brain tissues. It has been officially determined by liquid chromatographic method with UV detection [3]. Figure 1: Structures of NMD. Various analytical methods for the measurement of this compound have been reported. These include HPLC [4], LC-MS-MS [5], LC-MS [6], and GC with electron capture detection [7]. These techniques are highly expensive and not affordable for the routine analysis of dosage forms. Various analytical techniques that have been reported for this drug in therapeutics include atomic absorption spectrophotometry [8], polarography [9], spectrofluorimetry [10], and spectrophotometry [11–16]. Many of the reported methods are time consuming and require expensive experimental setup [4–7], and polarographic methods are less sensitive [9]. Besides, the reported spectrophotometric methods are less sensitive [11–16]

References

[1]  M. S. Langley and E. M. Sorkin, “Nimodipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease,” Drugs, vol. 37, no. 5, pp. 669–699, 1989.
[2]  J. E. F. Reynolds Martindale, The Extra Pharmacopeia, Pharmaceutical Press, London, UK.
[3]  G. Ragno, M. Veronico, and C. Vetuschi, “Analysis of nimodipine and its photodegradation product by derivative spectrophotometry and gas chromatography,” International Journal of Pharmaceutics, vol. 119, no. 1, pp. 115–119, 1995.
[4]  D. B. Yang, J. B. Zhu, R. Q. Lv, Z. G. Hu, and J. Q. Shen, “Liquid chromatographic method for determination of free and niosome-entrapped nimodipine in mouse plasma and different tissues,” Analalytical Letters, vol. 41, pp. 533–542, 2008.
[5]  F. Qiu, X. Chen, X. Li, and D. Zhong, “Determination of nimodipine in human plasma by a sensitive and selective liquid chromatography-tandem mass spectrometry method,” Journal of Chromatography B, vol. 802, no. 2, pp. 291–297, 2004.
[6]  W. M. Muck, “Enantiospecific determination of nimodipine in human plasma by liquid chromatography-tandem mass spectrometry,” Journal of Chromatography A, vol. 712, no. 1, pp. 45–53, 1995.
[7]  P. Jakobsen, E. O. Mikkelsen, J. Laursen, and F. Jensen, “Determination of nimodipine by gas chromatography using electron-capture detection; External factors influencing nimodipine concentrations during intravenous administration,” Journal of Chromatography, vol. 374, no. 2, pp. 383–387, 1986.
[8]  M. Canlica and S. Islimyeli, “The atomic absorption spectrophotometric method for indirect determination of nimodipine in tablets,” Turkish Journal of Chemistry, vol. 29, no. 2, pp. 141–146, 2005.
[9]  J. A. Squella, J. C. Sturm, R. Lenac, and L. J. Nunez-Vergara, “Polarographic and spectrophotometric determination of nimodipine in tablets,” Analytical Letters, vol. 25, pp. 281–292, 1992.
[10]  F. Belal, A. A. Al-Majed, S. Julkhuf, and N. Y. Khalil, “Spectrofluorometric determination of nimodipine in dosage forms and human urine,” Pharmazie, vol. 58, no. 12, pp. 874–876, 2003.
[11]  S. Nirmala Bharathi, M. S. Prakash, M. Nagarajan, and K. Asok Kumar, “Spectrophotometric determination of nimodipine and its formulations,” Indian Drugs, vol. 36, no. 10, pp. 661–662, 1999.
[12]  K. P. R. Chowdary and G. Devala Rao, “A new spectrophotometric method for the determination of nimodipine,” Indian Drugs, vol. 32, no. 11, pp. 548–550, 1995.
[13]  M. N. Reddy, T. K. Murthy, K. V. Rao Kanna, A. V. Gopal Hara, and D. G. Sankar, “New spectrophotometric methods for the determination of nimodipine,” Indian Drugs, vol. 38, no. 3, pp. 140–142, 2001.
[14]  V. Ravichandran, M. T. Sulthan, A. Shameen, M. Balakumar, S. Raghuraman, and V. Sankar, “Spectrophotometric method for the determination of nimodipine in pharmaceutical dosage forms,” Indian Journal of Pharmaceutical Science, vol. 63, pp. 425–427, 2001.
[15]  H. D. Revanasiddappa, S. M. Mallegowda, H. N. Deepakumari, and K. B. Vinay, “Spectrophotometric determination of nitrazepam and nimodipine in pure and the tablet dosage forms,” Asian Journal of Biochemical and Pharmaceutical Research, vol. 1, pp. 70–77, 2011.
[16]  H. D. Revanasiddappa, S. M. Mallegowda, H. N. Deepakumari, and K. B. Vinay, “Spectrophotometric methods for the determination of nimodipine in pure and in pharmaceutical preparations,” Jordan Journal of Chemistry, vol. 6, pp. 413–422, 2011.
[17]  H. D. Revanasiddappa, H. N. Deepakumari, S. M. Mallegowda, and K. B. Vinay, “Facile spectrophotometric determination of nimodipine and nitrazepam in pharmaceutical preparations,” Analele Universit??ii din Bucure?ti-Chimie, vol. 20, pp. 189–196, 2011.
[18]  H. D. Revanasiddappa, S. M. Mallegowda, H. N. Deepakumari, and K. B. Vinay, “Spectrophotometric methods for the determination of nimodipine in pure and in pharmaceutical preparations,” Jordan Journal of Chemistry, vol. 6, pp. 413–422, 2011.
[19]  ICH, “Note for Guidance on Validation of Analytical Procedures: Methodology Q2B,” 1996.
[20]  International Conference On Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procadures: Text and Methodology Q2(R 1), Complimentary Guideline on Methodology, dated 06 November 1996, London, UK, November 2005.
[21]  H. Zavis, D. Ludvik, K. Milan, S. Liadidlaw, and V. Frantisk, Handbook of Organic Reagents in Inorganic Anaslysis, Eds: University of Aberdem, Ellis Horwood Limited, John Wiley & Sons, London, UK, 1976.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133